These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 23071250)

  • 1. Special series on comparative effectiveness research: challenges to real-world solutions to quality improvement in personalized medicine.
    Browman GP
    J Clin Oncol; 2012 Dec; 30(34):4188-91. PubMed ID: 23071250
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative effectiveness research, genomics-enabled personalized medicine, and rapid learning health care: a common bond.
    Ginsburg GS; Kuderer NM
    J Clin Oncol; 2012 Dec; 30(34):4233-42. PubMed ID: 23071236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effectiveness research in oncology: an overview.
    Lyman GH; Levine M
    J Clin Oncol; 2012 Dec; 30(34):4181-4. PubMed ID: 23071249
    [No Abstract]   [Full Text] [Related]  

  • 4. Delivering precision medicine in oncology today and in future-the promise and challenges of personalised cancer medicine: a position paper by the European Society for Medical Oncology (ESMO).
    Ciardiello F; Arnold D; Casali PG; Cervantes A; Douillard JY; Eggermont A; Eniu A; McGregor K; Peters S; Piccart M; Popescu R; Van Cutsem E; Zielinski C; Stahel R
    Ann Oncol; 2014 Sep; 25(9):1673-1678. PubMed ID: 24950979
    [No Abstract]   [Full Text] [Related]  

  • 5. Defining precision medicine.
    Burki TK
    Lancet Oncol; 2017 Dec; 18(12):e719. PubMed ID: 29153736
    [No Abstract]   [Full Text] [Related]  

  • 6. Integrated patient and tumor genetic testing for individualized cancer therapy.
    Hertz DL; McLeod HL
    Clin Pharmacol Ther; 2016 Feb; 99(2):143-6. PubMed ID: 26537014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expectations to Patient-Reported Outcome (PRO) in Oncology - PRO for a purpose, when and how?
    Pappot H; Taarnhøj GA
    Acta Oncol; 2020 Jun; 59(6):611-612. PubMed ID: 32253960
    [No Abstract]   [Full Text] [Related]  

  • 8. Emerging Biomarkers in the Era of Personalized Cancer Medicine.
    Ricciuti B; Leonardi GC; Brambilla M
    Dis Markers; 2019; 2019():5907238. PubMed ID: 31485277
    [No Abstract]   [Full Text] [Related]  

  • 9. How comparative effectiveness research can help advance 'personalized medicine' in cancer treatment.
    Ramsey SD; Veenstra D; Tunis SR; Garrison L; Crowley JJ; Baker LH
    Health Aff (Millwood); 2011 Dec; 30(12):2259-68. PubMed ID: 22147853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brave-ish New World--What's Needed to Make Precision Oncology a Practical Reality.
    MacConaill LE; Lindeman NI; Rollins BJ
    JAMA Oncol; 2015 Oct; 1(7):879-80. PubMed ID: 26181886
    [No Abstract]   [Full Text] [Related]  

  • 11. Epilogue: the peril and the promise of comparative effectiveness research in oncology.
    Lyman GH; Levine M
    J Clin Oncol; 2012 Dec; 30(34):4282. PubMed ID: 23071238
    [No Abstract]   [Full Text] [Related]  

  • 12. Personalized medicine: CCO's vision, accomplishments and future plans.
    Guo J; Kamel-Reid S; Rutherford M; Hart J; Melamed S; Pollett A
    Healthc Q; 2015; 17 Spec No():41-3. PubMed ID: 25562133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Publication of tumor marker research results: the necessity for complete and transparent reporting.
    McShane LM; Hayes DF
    J Clin Oncol; 2012 Dec; 30(34):4223-32. PubMed ID: 23071235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Precision Oncology and "Molecular Tumor Boards" - Concepts, Chances and Challenges].
    Holch JW; Westphalen CB; Hiddemann W; Heinemann V; Jung A; Metzeler KH
    Dtsch Med Wochenschr; 2017 Nov; 142(22):1676-1684. PubMed ID: 29078213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cancer: three eras of personalized medicine].
    Jordan B
    Med Sci (Paris); 2017 Oct; 33(10):905-908. PubMed ID: 28994388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical Oncology in the Age of Genomic Medicine.
    Weber TK
    Surg Oncol Clin N Am; 2015 Oct; 24(4):xiii-xv. PubMed ID: 26363545
    [No Abstract]   [Full Text] [Related]  

  • 17. Data acquisition, tumor heterogeneity and precision medicine: future challenges for oncologic comparative effectiveness research.
    Benson AB
    J Comp Eff Res; 2013 Jan; 2(1):17-21. PubMed ID: 24236518
    [No Abstract]   [Full Text] [Related]  

  • 18. NCCN molecular testing white paper: effectiveness, efficiency, and reimbursement.
    Engstrom PF; Bloom MG; Demetri GD; Febbo PG; Goeckeler W; Ladanyi M; Loy B; Murphy K; Nerenberg M; Papagni P; Robson M; Sweetman RW; Tunis S; Demartino J; Larsen JK;
    J Natl Compr Canc Netw; 2011 Dec; 9 Suppl 6():S1-16. PubMed ID: 22203777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personalized Medicine: Genomics Trials in Oncology.
    Hayes DF; Schott AF
    Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular-Genetic Diagnosis and Molecular-Targeted Therapy in Cancer: Challenges in the Era of Precision Medicine].
    Miyachi H
    Rinsho Byori; 2015 Oct; 63(10):1188-93. PubMed ID: 26897855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.